Aliso Viejo-based Avanir Pharmaceuticals, the biopharmaceuticals firm focused on treatments for central nervous system disorders, has received $30M in a debt funding round, according to lenders Oxford FInance and Silicon Valley Bank. Avanir will use the funding to expand its product line and working capital. Terms of the debt financing were not announced.